论文部分内容阅读
肝细胞癌(hepatocellular carcinoma,HCC)是我国的常见肿瘤之一,发病率仅次于肺癌和胃癌,占第3位[1]。我国每年死于肝癌的患者约为11万人,占世界肝癌死亡人数的45%[1]。肝癌的诊断起自20世纪60年代,当时主要通过患者的临床表现诊断,并通过经皮肝穿刺活检证实;20世纪70年代甲胎?
Hepatocellular carcinoma (HCC) is one of the common tumors in our country, the incidence is second only to lung cancer and gastric cancer, accounting for 3 [1]. About 110,000 people die of liver cancer each year in our country, accounting for 45% of the world’s liver cancer deaths [1]. The diagnosis of liver cancer since the 1960s, when mainly through the clinical manifestations of patients diagnosed and confirmed by percutaneous liver biopsy; the 20th century, the 1970s,